Desai Pathology introduces RT-PCR testing for over 20 infectious diseases in Kolhapur

Desai Pathology introduces RT-PCR testing for over 20 infectious diseases in Kolhapur

Kolhapur, October 6, 2023 – A new era of high-end and affordable diagnostics has dawned upon in Kolhapur. The city-based Desai Pathology, a state-of-the-art laboratory has introduced comprehensive range of RT-PCR tests for more accurate test reports. By establishing a Healthtech partnership by Mylab, Desai Pathology becomes the first lab in Kolhapurto provide RT-PCR testing for an array of diseases such as HIV, Hepatitis C and B, Blood Donor Testing, Tuberculosis, Chikungunya, Dengue, Malaria, and Various Bacterial Infections, Cancer and genetic diseases.

Desai Pathology is equipped with the latest diagnostic machines from Mylab and staffed by a team of highly skilled professionals dedicated to providing accurate and timely results. This ensures that individuals in the city can receive the necessary tests promptly and efficiently, without the need to travel to distant facilities. Moreover, the patients can expect reduced waiting periods, enabling healthcare providers to promptly diagnose and initiate appropriate treatment plans.

Dr. Sanjay Desai, Owner of Desai Pathology., said, “Healthtech partnership by Mylabhas empowered us to deliver precise and personalized care, and elevates our reputation as a trusted diagnostic center. By embracing molecular diagnostics, we are better equipped to meet the needs of our patients and doctors. We invite residents to experience the convenience and reliability of our testing services.”

Dr. Gautam Wankhede, Director of Medical Affairs, Mylab Discovery Solutions said,.”Mylab’s fever panel is a hugely beneficial kit as it enables testing of multiple diseases such as Malaria, Chikungunya, Dengue, Zika, Leptospirosis and Salmonellosis bacterial species, and Leishmaniasis parasite at once, saving time and resources. Many of these diseases remain undiagnosed due to the similar nature of initial symptoms while the course of treatment is different for each. Hence, it is important to do a test with wide species coverage, which can identify and differentiate the infection source.”

‘Healthtech partnership by Mylab’ is an initiative to empower entrepreneurs in the hinterland to build molecular diagnostics lab to make diagnostics accessible to remote corners of the country. The lab owners and doctors will be able to provide quicker and quality diagnostic results to the patients, leading to desired clinical outcomes. They will not need to send patient samples to sophisticated labs, thus save time and cost.